The KRM Ayurveda IPO will issue 57,40,000 shares, and the total issue size is ₹77 crore. The nominal value per share is ₹10. The bidding window starts from January 21, 2026. It will remain open till January 23, 2026. The proposed allotment date is Jan 27, 2026. The shares will debut on the NSE SME on Jan 29, 2026.
Bids can be placed in the price range of ₹128 to ₹135, and each lot consists of 1,000 shares. To participate in the IPO, retail investors must apply for two lots, which translates to a minimum investment of ₹2,70,000. Investors applying under the sNII segment must bid for at least three lots, amounting to ₹4,05,000. The bNII investors will have to bid for at least 8 lots with ₹10,80,000.
KRM Ayurveda IPO Details
The following table provides an overview of the IPO’s key particulars:
| Particulars | Details |
| Bidding Opens | January 21, 2026 |
| Bidding Closes | January 23, 2026 |
| IPO Lot Size | 1,000 Shares |
| Face value | ₹10 per share |
| Price Band | ₹128 to ₹135 |
| Issue price | – |
| Offer for sale | – |
| Fresh issue | 57,40,000 shares (up to ₹77 Crore) |
| Issue Type | Bookbuilding |
| Listing at | NSE SME |
| Total Issue | 57,40,000 shares (up to ₹77 Crore) |
| Minimum Investment | ₹2,70,000 |
KRM Ayurveda IPO Timeline
Key dates related to the IPO are as follows:
| Particulars | Details |
| Bidding Opens | January 21, 2026 |
| Bidding Closes | January 23, 2026 |
| Allotment Scheduled | January 27, 2026 |
| Refund Process Starts | January 28, 2026 |
| Demat Credit of Shares | January 28, 2026 |
| Tentative Listing | January 29, 2026 |
| Cut-off for UPI Mandate | – |
KRM Ayurveda Key Performance Indicator
KRM Ayurveda’s Key Performance Indicators (KPIs) are outlined below:
| KPIs | FY 2023 | FY 2024 | FY 2025 |
| ROE (%) | 165.09 | 33.88 | 67.86 |
| ROCE (%) | 40.34 | 20.80 | 43.33 |
| Debt Equity (times) | 2.38 | 1.97 | 1.31 |
| RoNW (%) | 165.09 | 33.88 | 67.86 |
| PAT Margin (%) | 8.51 | 5.08 | 15.80 |
| EBITDA margin (%) | 12.35 | 10.92 | 24.96 |
| Price Book Value | – | – | 0.08 |
KRM Ayurveda IPO Financials
The important financial figures of the company are presented in the following table:
| Particulars (in ₹ lakh) | 2023 | 2024 | 2025 |
| Revenue | 8,937.59 | 6,757.17 | 7,694.97 |
| Total Asset | 3,947.53 | 4,391.10 | 6,678.57 |
| Profit | 759.80 | 341.22 | 1,209.72 |
KRM Ayurveda IPO Reservation
The reservation of shares across multiple investor segments is as follows:
| Investor Category | Reservation |
| Market Maker Shares Offered | 5,74,000 (10.00%) |
| QIB Shares | 25,74,000 (44.84%) |
| NII (HNI) Shares | 7,80,000 (13.59%) |
| Retail Shares | 18,12,000 (31.57%) |
| Total Shares | 57,40,000 (100.00% |
KRM Ayurveda India IPO Subscription Status
The subscription status of the IPO is shown in the table below:
| Day | NII | Individual Investor | Total |
| Day 1 | 1.70 | 1.71 | 1.22 |
| Day 2 | 2.49 | 2.47 | 1.77 |
| Day 3 |
KRM Ayurveda IPO Grey Market Premium (GMP Today)
The KRM Ayurveda IPO is currently trading at a GMP of ₹21, suggesting positive investor demand. The premium has risen from ₹20 to ₹21 over the last two days. The market sentiment looks optimistic, and listing gains of around 15.56% can be expected.
| Date | GMP (₹) | Estimated Listing Price | Estimated Listing Gain | Trend |
| 22-01-2026 | ₹12 | ₹147 | 8.89% | Neutral |
| 21-01-2026 | ₹12 | ₹147 | 8.89% |  |
| 20-01-2026 | ₹21 | ₹156 | 15.56% |  |
| 19-01-2026 | ₹20 | ₹155 | 14.81% | Neutral |
| 18-01-2026 | ₹20 | ₹155 | 14.81% | – |
Note: Since the GMP is derived from unofficial market activity, it remains subject to change with shifts in demand, market sentiment, and subscription levels.
KRM Ayurveda IPO Lot Size
Applications can be submitted based on the lot sizes mentioned below:
| Investor Type | Lots | Shares | Amount |
| Individual Investors – Retail (Min. Investment) | 2 | 2,000 | ₹2,70,000 |
| Individual Investors – Retail (Max. Investment) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min. Investment) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max. Investment) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min. Investment) | 8 | 8,000 | ₹10,80,000 |
Details of Anchor Investors in the KRM Ayurveda IPO
The following section contains information about the anchor investors in this IPO:
| Particulars | Details |
| Anchor Bid Opens | January 20, 2026 |
| Offered Shares | 15,42,000 shares |
| Portion Size | Up to 60% of the QIB Portion |
| 50% shares lock-in until (30 days) | February 26, 2026 |
| Remaining shares lock-in (90 days) | April 27, 2026 |
KRM Ayurveda IPO Prospectus
Additional information regarding the IPO is available in the documents listed below.:
| Draft Red Herring Prospectus (DRHP) | |
| Red Herring Prospectus (RHP) | |
| Anchor Investors | – |
| Final Prospectus | Not Disclosed |
About KRM Ayurveda
KRM Ayurveda Limited’s office is registered in Delhi, India. It was incorporated on September 03, 2019. Mr. Puneet Dhawan serves the company as the Managing Director and is also a promoter along with Mrs. Tanya Dhawan. Currently, it runs five clinics and six hospitals across the country.
KRM Ayurveda is engaged in the manufacturing and marketing of ayurvedic and herbal healthcare products, focusing on wellness, preventive care, and natural treatment solutions. The company operates within the ayurveda and traditional healthcare sector, catering to the growing demand for alternative and holistic medicine in India. The industry peers include Vaidya Sane Ayurved Laboratories Limited and Jeena Sikho Lifecare Limited.
| Issue Registrar | Skyline Financial Services Pvt.Ltd. |
| Lead Manager | NEXGEN Financial Solutions Pvt. Ltd. |
Objectives of the KRM Ayurveda IPO
The issue proceeds will be allocated towards the given objectives:
| S. No. | Purpose | Amount (₹ lakh) |
| 1. | Telemedicine facility development | 1,366.68 |
| 2. | CRM software & hardware infrastructure | 142.09 |
| 3. | Human resources | 543.82 |
| 4. | Loan repayment / prepayment | 1,250.00 |
| 5. | Working capital requirements | 2,290.00 |
| 6. | General corporate uses | – |
Strength Of KRM Ayurveda
KRM Ayurveda’s business is built on a focused approach to holistic healthcare, supported by the following strengths:
- Ayurvedic Expertise: The company follows authentic Ayurvedic principles, combining traditional therapies with yoga, meditation, and natural healing practices.
- Personalised Solutions: Health programs are designed around individual body constitutions and specific health needs, ensuring targeted and effective outcomes.
- Integrated Wellness Programs: The company’s offerings extend beyond consultation and include structured therapy, diet support, and lifestyle correction under a single platform.
- Awareness & Education Focus: Through workshops and wellness programs, KRM Ayurveda promotes awareness and encourages Ayurveda as a sustainable, everyday health practice
Risk of KRM Ayurveda
Investors should watch out for certain risks associated with KRM Ayurveda that can affect its operations and financial stability:
- Rented Premises: Several hospitals, clinics, and offices operate from leased properties. Any difficulty in renewing or relocating these facilities could disrupt operations.
- Employee Attrition: Higher staff turnover, especially among frontline and technical roles, may increase hiring costs and affect business operations and efficiency.
- Working Capital Requirements: The business requires substantial ongoing working capital. Any funding gaps could affect daily operations and future expansion plans.
- Regulatory and Product Quality Risks: Ayurvedic medicines face strict regulatory oversight. Any safety, compliance, or perception issues could impact reputation and sales.
KRM Ayurveda IPO Review
KRM Ayurveda provides an opportunity in the growing ayurvedic healthcare space. Its strength lies in its integrated ayurvedic healthcare model that combines personalised treatments, product manufacturing, and a growing network of clinics, hospitals, and telemedicine services. The positive GMP reflects improving market sentiment. However, regulatory compliance, working capital adequacy, and operational risks remain. This IPO aligns with investors seeking long-term exposure and having a higher risk tolerance.
Other Recent IPO List
For more IPO-focused analysis and updates, browse our latest IPO articles.
| Armour Security India IPO | Aritas Vinyl IPO |
| Amagi Media Labs IPO | Narmadesh Brass Industries IPO |
| GRE Renew Enertech IPO | INDO SMC IPO |
| KRM Ayurveda IPO | Avana Electrosystems IPO |
KRM Ayurveda IPO FAQs
The KRM Ayurveda IPO is a bookbuilding issue raising up to ₹77 crore through a fresh issue of 57,40,000 equity shares, and it will be listed on the NSE SME.
Investors can apply through their broker or online trading platform using UPI or ASBA. Applications must be placed within the subscription window and in the prescribed lot sizes.
The KRM Ayurveda IPO reflects a strong business presence in the ayurvedic healthcare sector and positive GMP trends. However, it carries operational and regulatory risks, and may suit investors with a high risk appetite.
Based on the current GMP of around ₹21, the IPO indicates listing gains of about 15%, though actual returns will depend on market conditions and demand at listing.
The KRM Ayurveda IPO opens for subscription on January 21, 2026, and closes on January 23, 2026.
The lot size is 1,000 shares. Retail investors must apply for a minimum of 2 lots (2,000 shares), amounting to ₹2,70,000 at the upper price band.
The allotment for the KRM Ayurveda IPO is scheduled for January 27, 2026.
The listing of the KRM Ayurveda IPO on the NSE SME is planned for January 29, 2026.
